A spokesperson for federal prosecutors says former Abercrombie & Fitch CEO Michael Jeffries and two other men have been ...

Soda, chips, cookies—brands are turning the stuff we used to consider junk food into nutritionally awesome upgrades. Or so ...

Sangamo Therapeutics shares rose after the company said the outcome of a recent successful interaction with the Food and Drug Administration provided a clear regulatory pathway to accelerated approval ...

Since Kennedy left the race in August, the “Make America Healthy Again” concept has permeated Trumpism, up-ending ...

At the GRx+Biosims 2024 conference, panelists explored challenges and progress in biosimilar interchangeability regulations ...

Antidepressants, the gold standard treatment for depression, don’t work for many people. Will psilocybin be an alternative?

The FDA issued a complete response letter (CRL) to Camurus, dealing a setback to the Swedish drugmaker’s efforts to bring its ...

FDA Commissioner Robert Califf criticized pharma companies on Monday for charging high prices for weight loss drugs. Califf ...

Leo Pharma is launching a new U.S. healthcare awareness campaign aimed at doctors to boost their understanding of a specific ...

Bose gave up on Sleepbuds after two generations. It was a sad, premature end for a promising product. The headphone maker ...

In addition to Cobenfy being approved for schizophrenia, there are other drugs with novel mechanisms being studied that may mean combination therapies or, at least, more options for patients in the ...

NanoViricides, Inc. (NYSE Amer.: NNVC ) (the “Company”), a clinical stage global leader in broad-spectrum antiviral nanomedicines, today announces that Anil R. Diwan, Ph.D., the Company’s President ...